Vensana Capital
Description
Vensana Capital is a prominent venture capital firm dedicated to investing in breakthrough innovations within the healthcare sector, specifically focusing on medical technology. Based in Minneapolis, the firm has established itself as a key player in supporting growth-stage companies that are developing transformative medical devices, diagnostics, digital health solutions, and tech-enabled services. Their strategic approach emphasizes partnering with visionary entrepreneurs to scale companies that address significant unmet clinical needs and improve patient outcomes.
The firm's investment strategy centers on providing growth capital to companies that have demonstrated strong clinical and commercial traction. Vensana Capital typically seeks out businesses with proven technologies, clear market opportunities, and experienced management teams. They are known for their hands-on approach, offering operational and strategic guidance to their portfolio companies beyond just financial investment, leveraging their deep industry expertise and extensive network within the healthcare ecosystem.
Vensana Capital has consistently raised substantial funds to support its investment thesis. Their most recent fund, Vensana Capital IV, successfully closed in 2021 with commitments totaling $325 million, underscoring investor confidence in their specialized focus and track record. Prior to this, Vensana Capital III closed in 2018 at $250 million, further demonstrating their increasing capacity to deploy significant capital. These fund sizes enable the firm to make meaningful investments, typically ranging from $10 million to $35 million for initial checks, with the capacity for substantial follow-on funding to support portfolio companies through various growth phases.
The firm's commitment to the medical technology space is evident in its long-term partnerships and its focus on companies poised for significant market disruption. Vensana Capital aims to accelerate the development and commercialization of innovative healthcare solutions, ultimately contributing to advancements in patient care and healthcare efficiency.
Investor Profile
Vensana Capital has backed more than 25 startups, with 4 new investments in the last 12 months alone. The firm has led 15 rounds, about 60% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Health Care, Medical, Medical Device.
- Led 1 rounds in the past year.
- Typical check size: $10M – $35M.
Stage Focus
- Series B (24%)
- Series Unknown (24%)
- Series A (16%)
- Series C (16%)
- Series D (8%)
- Private Equity (4%)
- Series G (4%)
- Series F (4%)
Country Focus
- United States (96%)
- France (4%)
Industry Focus
- Health Care
- Medical
- Medical Device
- Biotechnology
- Artificial Intelligence (Ai)
- Wellness
- Health Diagnostics
- Pharmaceutical
- Apps
- Hospital
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
